Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

ENSAT Stage I Adrenal Cortex Carcinoma 1Adrenocortical Carcinoma 1

Interventions

Mitotane 10Cisplatin 9pembrolizumab 7Doxorubicin 6Etoposide 5Specimen Handling 4Nivolumab 4Magnetic Resonance Spectroscopy 4relacorilant 3cabozantinib 3Cytoreduction Surgical Procedures 3sodium thiosulfate 2cixutumumab 2cemiplimab 2camrelizumab 2apatinib 2Trastuzumab 2Suramin 2Radiotherapy 2Ipilimumab 2Dichlorodiphenyldichloroethane 2Cyclophosphamide 2tipifarnib 1pegfilgrastim 1milademetan 1lenvatinib 1iodophenyl metomidate 1gossypol acetic acid 1fludarabine phosphate 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adrenocortical Carcinoma × Ethane × Clear all
NCT00304070 2024-02-28

Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor

Children's Oncology Group

Phase 3 Completed
78 enrolled 15 charts
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡